$0.6303
-0.0697[-9.96%]
At close: Apr 19
$0.6303
0[0.00%]
After Hours: 4:59PM EDT
Chemomab Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Chemomab Therapeutics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/09/2024 | AM | CMMB | Q1 | -$0.80 | — | — | — | $0.00 | — | — | — | Get Alert |
03/07/2024 | AM | CMMB | Q4 | -$0.72 | — | -$0.26 | — | $0.00 | — | $0.00 | — | Get Alert |
11/09/2023 | AM | CMMB | Q3 | -$0.70 | -$0.02 | -$0.34 | -1600.00% | $0.00 | — | $0.00 | — | Get Alert |
08/14/2023 | AM | CMMB | Q2 | -$0.54 | -$0.80 | -$0.72 | 10.00% | $0.00 | — | $0.00 | — | Get Alert |
05/11/2023 | AM | CMMB | Q1 | -$0.02 | -$0.03 | -$0.80 | -2566.67% | $0.00 | — | $0.00 | — | Get Alert |
03/30/2023 | AM | CMMB | Q4 | -$0.44 | — | -$0.72 | — | $0.00 | — | $0.00 | — | Get Alert |
11/11/2022 | AM | CMMB | Q3 | -$0.26 | -$0.33 | -$0.70 | -112.12% | $0.00 | — | $0.00 | — | Get Alert |
08/12/2022 | AM | CMMB | Q2 | -$0.26 | -$0.25 | -$0.54 | -116.00% | $0.00 | — | $0.00 | — | Get Alert |
05/12/2022 | AM | CMMB | Q1 | -$0.22 | -$0.24 | -$0.02 | 90.83% | $0.00 | — | $0.00 | — | Get Alert |
03/09/2022 | AM | CMMB | Q4 | -$0.01 | -$0.10 | -$0.44 | -340.00% | $0.00 | — | $0.00 | — | Get Alert |
11/12/2021 | AM | CMMB | Q3 | $0.01 | -$0.14 | -$0.26 | -85.71% | $0.00 | — | $0.00 | — | Get Alert |
08/13/2021 | AM | CMMB | Q2 | -$0.01 | -$0.11 | -$0.26 | -136.36% | — | — | $0.00 | — | Get Alert |
05/13/2021 | AM | CMMB | Q1 | — | -$0.34 | -$0.22 | 35.29% | — | — | $0.00 | — | Get Alert |
Chemomab Therapeutics (CMMB) is scheduled to report earnings on May 9, 2024. The last reported earnings were for reported on March 7, 2024 for Q4.
The Actual EPS was $-0.26, which missed the estimate of $0.00.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.